Novartis Diovan heart study retracted; Almac, Queen's University partner on cancer-drug discovery;

@FierceBiotech: In growing diabetes market, Sanofi looks beyond iPhone for mobile glucose testing. Article from FierceBiotech IT | Follow @FierceBiotech

@JohnCFierce: Crowdfunding cash for biotech startup Perle (diabetes). Press release | Follow @JohnCFierce

@Ry_McBride: UPDATED: No end of biotech IPO frenzy in sight. Special report | Follow @Ry_McBride

@EmilyMFierce: Making iPS cells safer for use in humans through the study of a cellular odd fellow. More from Stanford | Follow @EmilyMFierce

> U.K.-based Almac Discovery has announced a £13 million ($20.3 million) partnership with the Centre for Cancer Research and Cell Biology (CCRCB) at Queen's University Belfast to accelerate cancer-focused drug discovery in Northern Ireland. Release

> The medical journal The Lancet has formally retracted the Novartis ($NVS) Diovan Jikei Heart Study paper, originally published in 2007. Story

> Researchers used induced pluripotent stem cells to identify kidney disease defect, and the findings point to a new potential strategy for preventing and treating the disease. Release

Pharma News

@FiercePharma: Glaxo said to be near $1.6B Lucozade-Ribena sale to Japan's Suntory. Latest in series of brand sales. ICYMI yesterday | Follow @FiercePharma

@EricPFierce: Bristol-Myers Squibb flees high cost of East Coast with new center in Tampa, FL. Moving some jobs from NJ. Report | Follow @EricPFierce

@CarlyHFierce: Departure of new Vivus CEO Zook tops the list of this week's hirings, firings & other movements in pharma/biotech. Chutes & Ladders | Follow @CarlyHFierce

> Would GSK pull out of China altogether? More

> 'Doctor-2' in Elan, Wyeth insider trading case said to be well connected Alzheimer's doc. Article

> Another compounder recalls drugs because of lapse in outside testing. Story

Medical Device News

@FierceMedDev: Enzymatics jumps into next-gen Dx space with $50M startup buy. More | Follow @FierceMedDev

@MarkHFierce: Better sanitation is linked to more Alzheimer's cases. Article | Follow @MarkHFierce

@MichaelGFierce: Myriad rolls out next-gen Dx for 8 major cancers. Story | Follow @MichaelGFierce

> Rented Medtronic tools linked to possible disease exposure. News

> Enzymatics jumps into next-gen Dx space with $50M startup buy. Report

> Report: KKR favored bidder in Panasonic's billion-dollar health unit sale. Story

> India advances effort to modernize medical device regs. Item

And Finally... Just for kicks, check out this bizarre-looking web structure in the Peruvian Amazon that is mystifying scientists.

Suggested Articles

Biogen stunned the biotech world Tuesday when it said it would file aducanumab for approval. Now that the dust has settled, what are analysts saying?

Biocytogen uses chromosome engineering for the in situ replacement of mouse antibody genes with the human counterparts.

Eli Lilly is canning the lead program for the crown jewel of its $1.6 billion Armo buyout after the drug put up a poor showing in pancreatic cancer.